SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-137092
Filing Date
2023-05-05
Accepted
2023-05-05 16:07:34
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d416458d10ka.htm   iXBRL 10-K/A 518489
2 EX-31.1 d416458dex311.htm EX-31.1 3559
3 EX-31.2 d416458dex312.htm EX-31.2 3885
  Complete submission text file 0001193125-23-137092.txt   813151

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20221231.xsd EX-101.SCH 4942
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20221231_cal.xml EX-101.CAL 654
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20221231_def.xml EX-101.DEF 17677
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20221231_lab.xml EX-101.LAB 23279
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20221231_pre.xml EX-101.PRE 19256
10 EXTRACTED XBRL INSTANCE DOCUMENT d416458d10ka_htm.xml XML 8698
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37627 | Film No.: 23893832
SIC: 2834 Pharmaceutical Preparations